Dana-Farber Cancer Institute
Locations
Transplant Summary
Overview
Dana-Farber Brigham Cancer Center hematopoietic stem cell transplantation program is an adult oncology effort of Dana-Farber and the Brigham and Women's Hospital. Dana-Farber Cancer Institute and Boston Children's Hospital work together to provide pediatric stem cell transplantation.This center has been performing allogeneic transplants since 1984 and has been an NMDP transplant center since March 1989.
Attending physicians
Adult - Joseph H. Antin, Phillipe Armand, Corey Cutler, Mahasweta Gooptu, Vincent Ho, Amar Kelkar, John Koreth, Sarah Nikiforow, Rizwan Romee, Roman Shapiro, Robert Soiffer
Pediatric - Suneet Agarwal, Francesca Alvarez Calderon, Susanne Baumeister, Christy Duncan, Ulrike Gerdemann, Lev Gorfinkel, Emily Heikamp, Malika Kapadia, Amy Keating, Leslie Lehmann, Miki Nishitani, Susan Prockop, Jared Rowe, Grant Rowe, Takuto Takahashi, Christina Ullrich, Franziska Wachter, Lara WahlsterTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
Discounted and free housing resources on a need basisPatient survival information for this center
Dana-Farber Brigham Cancer Center
This center's actual 1-year survival results are above the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 754 patients.The actual 1-year survival of these patients is 80.6%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 71.6% and 77.5%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.Dana-Farber/Boston Children's Cancer and Blood Disorders Center
This center's actual 1-year survival results are above the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 164 patients.The actual 1-year survival of these patients is 91.9%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 80.7% and 90.9%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
932
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow14PBSC130Cord blood0Total144Unrelated donorMarrow27PBSC412Cord blood0Total439Total allogeneicMarrow41PBSC542Cord blood0Total583AutologousMarrowBoth marrow & PBSC 349PBSC—Cord blood—Total349Total combinedMarrowBoth marrow & PBSC 932PBSC—Cord blood0Total932Total pediatric transplants
226
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow44PBSC5Cord blood2Total51Unrelated donorMarrow45PBSC9Cord blood13Total67Total allogeneicMarrow89PBSC14Cord blood15Total118AutologousMarrowBoth marrow & PBSC 108PBSC—Cord blood—Total108Total combinedMarrowBoth marrow & PBSC 211PBSC—Cord blood15Total226All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-184619-445645-645865+35Total195Unrelated 0-186119-447345-6415365+219Total506Autologous 0-1810219-448645-6417665+93Total457Total 0-1820919-4421545-6438765+347Total1158Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorGregory BourdeauPhone: (617) 632-5846NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Dana-Farber Cancer Inst
450 Brookline Ave Boston, MA 2215 Phone:877-441-DFCI (441-3324). For more information about this program: https://www.dana-farber.org/adult-survivorship-program/ (Opens in a new tab)Overview
The staff at our adult survivorship clinic can help you manage long-term and late effects of cancer treatment and guide you in living a healthier lifestyle. At your appointment, we will review your medical records, including past cancer diagnosis and treatment, current health status, and general quality of life. We'll provide you with a comprehensive summary of recommendations that can serve as a useful guide to you and your primary care doctor, outlining potential late effects and offering helpful medical information related your past treatment and future care. We offer specialized expertise and services including: Cardiologists who work to treat and prevent heart damage and related problems sometimes associated with cancer treatment; Community resource specialists to help you find survivorship resources near your home, such as advocacy, employment rights, fertility resources, financial support, health insurance, and support groups; Endocrinologists who diagnose and treat issues related to endocrine glands, such as the thyroid, adrenal glands, and pituitary glands; Exercise consultations with an exercise physiologist, to help survivors of any cancer diagnosis experience the benefits of safe, effective, regular physical activity, answer fitness-related questions, and provide personalized exercise tips; Gynecologists to help with fertility issues and sexual health; Lymphologists to diagnose and treat issues related to the immune system in cancer survivors; Nephrologists who work with survivors to diagnose and treat issues related to the kidneys; Nutrition counseling to strengthen healthy eating habits for cancer survivors; Education and support, including classes, support groups, and individual appointments designed to help cancer survivors and their family members address the emotional, mental, social, and spiritual aspects of surviving cancer; Sexual health program to address changes in sexual health during and after cancer treatment
Staff
Program Director:Corey Cutler, MDMedical Specialties in Program
Cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, genetic counseling, nutrition/dietetics, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 12 months after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital